Making prospective registration of observational research a reality

Science Translational Medicine

Volumn 6, Issue 224, 2014, Pages

  Dal Ré, Rafael ^a,i,j,k,l   Ioannidis, John P ^b,i,j,k   Bracken, Michael B ^c,i,j,k   Buffler, Patricia A ^d,i,j,k   Chan, An Wen ^e,i,j,k   Franco, Eduardo L ^f,i,j,k   La Vecchia, Carlo ^g,i,j,k   Weiderpass, Elisabete ^h,i,j,k  

^a Clinical Research Program   (Spain)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF MILAN   (Italy)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ Department of Research Cancer Registry of Norway ^*  (Norway)

^j UNIVERSITY OF TROMSØ   (Norway)

^k FOLKHÄLSAN RESEARCH CENTER   (Finland)

^l UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL PROTOCOL; FALSE POSITIVE RESULT; FUNDING; JOURNAL IMPACT FACTOR; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; OBSERVATIONAL STUDY; PEER REVIEW; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLICATION; REGISTRATION; RESEARCH ETHICS; STANDARD;

CLINICAL PROTOCOLS; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PROSPECTIVE STUDIES;

EID: 84896351646     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007513     Document Type: Note

References (38)

1. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Workshop: Enhancement of the scientific process and transparency of observational epidemiology studies. (Brussels, Belgium, November 2009). http://members.ecetoc.org/Documents/Document/20100108131222-WR-18.pdf.
2. The Lancet, Should protocols for observational research be registered? Lancet 375, 348 (2010).
3. Editors, The registration of observational studies - When metaphors go bad. Epidemiology 21, 607-609 (2010).
4. T. L. Lash, Preregistration of study protocols is unlikely to improve the yield from our science, but other strategies might. Epidemiology 21, 612-613 (2010).
5. J. P. Vandenbroucke, Preregistration of epidemiologic studies: An ill-founded mix of ideas. Epidemiology 21, 619-620 (2010).
6. D. A. Savitz, Registration of observational studies does not enhance validity. Clin. Pharmacol. Ther. 90, 646-648 (2011).
7. M. B. Bracken, Preregistration of epidemiology protocols: A commentary in support. Epidemiology 22, 135-137 (2011).
8. J. M. Samet, To register or not to register. Epidemiology 21, 610-611 (2010).
9. J. P. Ioannidis, The importance of potential studies that have not existed and registration of observational data sets. JAMA 308, 575-576 (2012).
10. C. De Angelis, J. M. Drazen, F. A. Frizelle, C. Haug, J. Hoey, R. Horton, S. Kotzin, C. Laine, A. Marusic, A. J. Overbeke, T. V. Schroeder, H. C. Sox, M. B. Van Der Weyden, International Committee of Medical Journal Editors, Clinical trial registration: A statement from the international Committee of Medical Journal Editors. Ann. Intern. Med. 141, 477-478 (2004).
11. F. K. Kavvoura, G. Liberopoulos, J. P. Ioannidis, Selection in reported epidemiological risks: An empirical assessment. PLOS Med. 4, e79 (2007).
12. P. Boffetta, J. K. McLaughlin, C. La Vecchia, R. E. Tarone, L. Lipworth, W. J. Blot, False-positive results in cancer epidemiology: A plea for epistemological modesty. J. Natl. Cancer Inst. 100, 988-995 (2008).
13. S. S. Young, A. Karr, Deming, data, and observational studies: A process out of control and needing fixing. Significance 8, 116-120 (2011).
14. G. G. Swaen, O. Teggeler, L. G. van Amelsvoort, False positive outcomes and design characteristics in occupational cancer epidemiology studies. Int. J. Epidemiol. 30, 948-954 (2001).
15. J. P. Ioannidis, Why most discovered true associations are inflated. Epidemiology 19, 640-648 (2008).
16. D. A. Savitz, Commentary: Prior specification of hypotheses: Cause or just a correlate of informative studies? Int. J. Epidemiol. 30, 957-958 (2001).
17. World Medical Association, Declaration of Helsinki, Seoul, Korea, October 2008. www.wma.net/es/30publications/10policies/b3/17c.pdf.
18. J. P. Vandenbroucke, Registering observational research: Second thoughts. Lancet 375, 982-983 (2010).
19. A. W. Chan, J. M. Tetzlaff, D. G. Altman, A. Laupacis, P. C. Gøtzsche, K. Krleža-Jerić, A. Hróbjartsson, H. Mann, K. Dickersin, J. A. Berlin, C. J. Doré, W. R. Parulekar, W. S. Summerskill, T. Groves, K. F. Schulz, H. C. Sox, F. W. Rockhold, D. Rennie, D. Moher, SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Ann. Intern. Med. 158, 200-207 (2013).
20. L. Thomas, E. D. Peterson, The value of statistical analysis plans in observational research: Defining high-quality research from the start. JAMA 308, 773-774 (2012).
21. K. Krleza-Jerić, A. W. Chan, K. Dickersin, I. Sim, J. Grimshaw, C. Gluud, Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330, 956-958 (2005).
22. J. P. Vandenbroucke, Observational research, randomised trials, and two views of medical science. PLOS Med. 5, e67 (2008).
23. R. Dal-Ré, K. Fauria, N. Gramunt, J. L. Molinuevo, Clinical observational research on Alzheimer's disease: What clinical trial registries can tell. J. Alzheimers Dis. 34, 183-190 (2013).
24. Council for International Organizations of Medical Sciences, International ethical guidelines for epidemiological studies. Geneva. CIOMS, 2009.
25. M. B. Bracken, D. Baker, J. A. Cauley, C. Chambers, J. Culhane, D. Dabelea, D. Dearborn, C. D. Drews-Botsch, D. J. Dudley, M. Durkin, B. Entwisle, L. Flick, D. Hale, J. Holl, M. Hovell, M. Hudak, N. Paneth, B. Specker, M. Wilhelm, S. Wyatt, New models for large prospective studies: Is there a risk of throwing out the baby with the bathwater? Am. J. Epidemiol. 177, 285-289 (2013).
26. M. J. Khoury, T. K. Lam, J. P. Ioannidis, P. Hartge, M. R. Spitz, J. E. Buring, S. J. Chanock, R. T. Croyle, K. A. Goddard, G. S. Ginsburg, Z. Herceg, R. A. Hiatt, R. N. Hoover, D. J. Hunter, B. S. Kramer, M. S. Lauer, J. A. Meyerhardt, O. I. Olopade, J. R. Palmer, T. A. Sellers, D. Seminara, D. F. Ransohoff, T. R. Rebbeck, G. Tourassi, D. M. Winn, A. Zauber, S. D. Schully, Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol. Biomarkers Prev. 22, 508-516 (2013).
27. International Committee of Medical Journal Editors, Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. www.icmje.org.
28. U.S. Food and Drug Administration, FDA amendments act (FDAAA) of 2007: Public law No.110-85. 110th Congress. Sept 27, 2007. www.gpo.gov/fdsys/pkg/PLAW- 110publ85/pdf/PLAW-110publ85.pdf.
29. Communication from the Commission regarding the guideline on the data fields contained in the clinical trials database provided for in article 11 of Directive 2001/20/EC to be included in the database on medicinal products provided for in Article 57 of Regulation (EC) No. 726/2004. European Commission, ed. Official Journal of the European Union, 2008. (2008/C 168/02). http://ec.europa.eu/health/files/eudralex/vol-10/2008-07/c- 16820080703en00030004-en.pdf.
30. World Medical Association, Declaration of Helsinki. Fortaleza, Brazil, October 2013. www.wma.net/en/20activities/10ethics/10helsinki/index.html.
31. A. M. Gülmezoglu, T. Pang, R. Horton, K. Dickersin, WHO facilitates international collaboration in setting standards for clinical trial registration. Lancet 365, 1829-1831 (2005).
32. WHO, International standards for clinical trials registration. (Geneva, 2012). http://apps.who.int/iris/bitstream/10665/76705/1/9789241504294-eng.pdf.
33. WHO, International Clinical Trials Registry Platform (ICTRP). www.who.int/ictrp/en.
34. D. A. Zarin, N. C. Ide, T. Tse, W. R. Harlan, J. C. West, D. A. B. Lindberg, Issues in the registration of clinical trials. JAMA 297, 2112-2120 (2007).
35. I. Chalmers, P. Glasziou, F. Godlee, All trials must be registered and the results published. BMJ 346, f105 (2013).
36. A. A. Alsheikh-Ali, W. Qureshi, M. H. Al-Mallah, J. P. Ioannidis, Public availability of published research data in high-impact journals. PLOS ONE 6, e24357 (2011).
37. M. A. Hernán, A. J. Wilcox, Epidemiology, data sharing, and the challenge of scientific replication. Epidemiology 20, 167-168 (2009).
38. ROARMAP, Registry of Open Access Repositories Mandatory Archiving Policies. http://roarmap.eprints.org. Downloaded from stm.sciencemag.org on March 14, 2014